Additional Details
A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease
Baylor Scott and White Health - Advanced Lung Disease Specialists - Dallas
Dallas, TX 75246-2073